Drug Name |
GPD-1116
|
Indication |
Disease Entry |
ICD 11 |
Status |
REF |
Asthma |
CA23
|
Phase 2 |
[1] |
------------------------------------------------------------------------------------ |
|
|
|
|
Structure |
|
|
3D MOL
|
2D MOL
|
#Ro5 Violations (Lipinski): 0 |
Molecular Weight (mw) |
352.4 |
|
Logarithm of the Partition Coefficient (xlogp) |
3.8 |
Rotatable Bond Count (rotbonds) |
3 |
Hydrogen Bond Donor Count (hbonddonor) |
1 |
Hydrogen Bond Acceptor Count (hbondacc) |
3 |
Chemical Identifiers |
- Formula
- C22H16N4O
- IUPAC Name
3-benzyl-5-phenyl-2H-pyrazolo[4,3-c][1,8]naphthyridin-4-one
- Canonical SMILES
-
C1=CC=C(C=C1)CC2=C3C(=NN2)C4=C(N=CC=C4)N(C3=O)C5=CC=CC=C5
- InChI
-
InChI=1S/C22H16N4O/c27-22-19-18(14-15-8-3-1-4-9-15)24-25-20(19)17-12-7-13-23-21(17)26(22)16-10-5-2-6-11-16/h1-13H,14H2,(H,24,25)
- InChIKey
-
NOZMPLJNURLIAQ-UHFFFAOYSA-N
|
Cross-matching ID |
- PubChem CID
- 9841417
- TTD ID
- D01XFZ
|
|
|
|
|
|
|
|